Core Laboratories

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$130,159
$123,585
$129,237
$134,397
Gross Profit
22,788
20,399
19,374
23,916
EBITDA
22,645
8,097
17,838
23,479
EBIT
15,258
4,380
14,174
19,803
Net Income
10,636
-154
7,403
11,745
Net Change In Cash
130,159
123,585
129,237
134,397
Free Cash Flow
13,923
3,081
16,234
10,371
Cash
31,188
22,107
19,157
21,474
Basic Shares
47,509
46,773
47,773
47,820

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$523,848
$509,790
$489,735
$470,252
Gross Profit
88,373
94,049
78,919
83,840
EBITDA
73,273
70,424
58,685
63,778
EBIT
58,320
54,640
41,524
45,262
Net Income
31,400
36,675
19,453
19,727
Net Change In Cash
523,848
509,790
489,735
470,252
Cost of Revenue
-2,275
3,897
Free Cash Flow
43,360
14,210
14,740
23,040
Cash
19,157
15,120
15,428
17,703
Basic Shares
47,685
47,523
46,813
46,690

Earnings Calls

Quarter EPS
2025-06-30
$0.19
2025-03-31
$0.14
2024-12-31
$0.22
2024-09-30
$0.25